Xin Yu

发表

Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson’s disease

Rongxia Liu, Kaoxiang Sun, Zi-Xin Wu, 2019, Drug delivery.

Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects

Kaoxiang Sun, Zi-Xin Wu, Dongyu Duan, 2018, International journal of nanomedicine.

Continuous dopaminergic stimulation counteracts l-DOPA-induced overactivity of Ca2+ in 6-OHDA-lesioned rats

Xinyu Zhao, Xin Yu, Jie Fu, 2022, Experimental Brain Research.

PCC0208009, an indirect IDO1 inhibitor, alleviates neuropathic pain and co-morbidities by regulating synaptic plasticity of ACC and amygdala.

G. Du, Yong-lin Gao, Jing-wei Tian, 2020, Biochemical pharmacology.